Table 3 NIH Revitalization Act of 1993 (PL 103-43)

The act reinforced existing NIH policies but with four major differences:

1. That NIH ensure that women and minorities be included in all clinical research

2. That women and minorities be included in phase III clinical trials in numbers adequate to allow for valid analyses of differences in the intervention

3. That cost is not allowed as an acceptable reason for excluding these groups

4. That NIH initiates programs and support for outreach efforts to recruit and retain women and minorities as participants in clinical studies